BusinessVeritas Pharma Announces Appointment of Accomplished Business Development and Strategy Professional, Justin KauselBy Nasdaq OMXMar 15, 2018, 7:15 AM UTC
BusinessVeritas Pharma Provides Year End Update on Company’s Activities to ShareholdersBy Nasdaq OMXJan 4, 2018, 11:14 PM UTC
BusinessVeritas’ Research Arm Cannevert Signs a Material Transfer Agreement with the Institute for Medical Cannabis of Puerto RicoBy Nasdaq OMXDec 5, 2017, 8:05 AM UTC
BusinessCannevert Scientists to Present Their First Peer-Reviewed Research at December’s Prestigious British Pharmacological Society Meeting in London, UKBy Nasdaq OMXNov 22, 2017, 9:15 PM UTC
BusinessVeritas’ Research Arm Cannevert Therapeutics Signs Letter of Intent with Fundación de Investigación (FDI) of Puerto Rico USA to Begin Human Trials of Its Lead Cannabis Strain for PainBy Nasdaq OMXNov 20, 2017, 8:05 AM UTC
BusinessVeritas Pharma Enters Binding Letter of Intent to Secure ACMPR License and Cannabis Growing FacilityBy Nasdaq OMXNov 18, 2017, 9:44 PM UTC
BusinessVeritas Pharma Initiates Cancer Research with Dr. Dmitri PetchkovskiBy Nasdaq OMXNov 14, 2017, 9:15 PM UTC
